{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:17:17Z","timestamp":1775081837762,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Intramural Research Program of KIST (Global RNAi Carrier Initiative)"},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2014M3A9E5073316"],"award-info":[{"award-number":["2014M3A9E5073316"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2014M3C1A3054141"],"award-info":[{"award-number":["2014M3C1A3054141"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2012K1A1A2A01055811"],"award-info":[{"award-number":["2012K1A1A2A01055811"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jconrel.2015.05.262","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T20:51:32Z","timestamp":1431463892000},"page":"105-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Co-delivery of chemosensitizing siRNA and an anticancer agent via multiple monocomplexation-induced hydrophobic association"],"prefix":"10.1016","volume":"210","author":[{"given":"Eunjung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changhwoa","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-San","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ick Chan","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sehoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2015.05.262_bb0005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nchembio839","article-title":"RNAi therapeutics: a potential new class of pharmaceutical drugs","volume":"2","author":"Bumcrot","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0010","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature07758","article-title":"The promises and pitfalls of RNA-interference-based therapeutics","volume":"457","author":"Castanotto","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0015","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.addr.2009.04.018","article-title":"siRNA delivery systems for cancer treatment","volume":"61","author":"Oh","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrg2968","article-title":"Current prospects for RNA interference-based therapies","volume":"12","author":"Davidson","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0025","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.biomaterials.2010.11.061","article-title":"The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells","volume":"32","author":"Cao","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nantod.2012.06.013","article-title":"Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance","volume":"7","author":"Creixell","year":"2012","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0035","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/j.biomaterials.2013.12.095","article-title":"Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles","volume":"35","author":"Li","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.biomaterials.2009.09.048","article-title":"The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance","volume":"31","author":"Patil","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0045","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1021\/nn103349h","article-title":"Simultaneous delivery of siRNA and paclitaxel via a \u201ctwo-in-one\u201d micelleplex promotes synergistic tumor suppression","volume":"5","author":"Sun","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0050","doi-asserted-by":"crossref","first-page":"9571","DOI":"10.1021\/nn4047925","article-title":"Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment","volume":"7","author":"Deng","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2007.05.021","article-title":"Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery","volume":"121","author":"Gary","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0060","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jconrel.2011.11.014","article-title":"Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers","volume":"161","author":"Scholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0065","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/smll.201001389","article-title":"Engineering nanocarriers for siRNA delivery","volume":"7","author":"Tan","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0070","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jconrel.2011.10.009","article-title":"Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design","volume":"158","author":"Buyens","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0075","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nbt1402","article-title":"A combinatorial library of lipid-like materials for delivery of RNAi therapeutics","volume":"26","author":"Akinc","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0080","doi-asserted-by":"crossref","first-page":"13338","DOI":"10.1021\/ja903028f","article-title":"Mesomorphic imidazolium salts: new vectors for efficient siRNA transfection","volume":"131","author":"Dobbs","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0085","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2217\/nnm.13.155","article-title":"Nonionic surfactant vesicles for delivery of RNAi therapeutics","volume":"8","author":"Paecharoenchai","year":"2013","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0090","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1021\/ja9617855","article-title":"A DNA\u2013lipid complex in organic media and formation of an aligned cast film","volume":"118","author":"Tanaka","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0095","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/cm000869g","article-title":"Self-assembled supramolecular films derived from marine deoxyribonucleic acid (DNA)-cationic surfactant complexes: large-scale preparation and optical and thermal properties","volume":"13","author":"Wang","year":"2001","journal-title":"Chem. Mater."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3816\/CBC.2009.n.005","article-title":"Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design","volume":"9","author":"Kassam","year":"2009","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/bm801109g","article-title":"Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug","volume":"10","author":"Beh","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/smll.201001358","article-title":"Heavy-atomic construction of photosensitizer nanoparticles for enhanced photodynamic therapy of cancer","volume":"7","author":"Lim","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0115","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1158\/1078-0432.CCR-06-0536","article-title":"Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen","volume":"12","author":"Yip","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0120","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrc883","article-title":"The BCL2 family: regulators of the cellular life-or-death switch","volume":"2","author":"Cory","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.45","article-title":"Therapeutic silencing of Bcl-2 by systemically administered siRNA nanotherapeutics inhibits tumor growth by autophagy and apoptosis and enhances the efficacy of chemotherapy in orthotopic xenograft models of ER (\u2212) and ER (+) breast cancer","volume":"2","author":"Tekedereli","year":"2013","journal-title":"Mol. Ther.\u2014Nucleic Acids"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0168-3659(02)00009-3","article-title":"Pluronic (R) block copolymers as novel polymer therapeutics for drug and gene delivery","volume":"82","author":"Kabanov","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0169-409X(00)00131-9","article-title":"Delivery of molecular and cellular medicine to solid tumors","volume":"46","author":"Jain","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0140","first-page":"4478","article-title":"Interstitial pressure-gradients in tissue-isolated and subcutaneous tumors \u2014 implications for therapy","volume":"50","author":"Boucher","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0145","first-page":"2497","article-title":"Role of extracellular matrix assembly in interstitial transport in solid tumors","volume":"60","author":"Netti","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0150","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1021\/nl900031y","article-title":"Mediating tumor targeting efficiency of nanoparticles through design","volume":"9","author":"Perrault","year":"2009","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0155","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.081626898","article-title":"Role of tumor\u2013host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors","volume":"98","author":"Pluen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0160","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1073\/pnas.1018382108","article-title":"Multistage nanoparticle delivery system for deep penetration into tumor tissue","volume":"108","author":"Wong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0165","doi-asserted-by":"crossref","first-page":"8502","DOI":"10.1021\/jp068571m","article-title":"Effect of headgroup on DNA-cationic surfactant interactions","volume":"111","author":"Dasgupta","year":"2007","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0170","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/ewjm.174.4.284","article-title":"Adjuvant therapy for breast cancer: who should get what?","volume":"174","author":"Chew","year":"2001","journal-title":"West. J. Med."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0175","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/S0960-9776(11)70315-0","article-title":"Adjuvant therapies for special types of breast cancer","volume":"20","author":"Colleoni","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.jconrel.2015.05.262_bb0180","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp800049w","article-title":"Pharmacokinetics and biodistribution of nanoparticles","volume":"5","author":"Li","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0169-409X(99)00059-9","article-title":"Noninvasive measurements for studying the tumoral pharmacokinetics of platinum anticancer drugs in solid tumors","volume":"41","author":"Dowell","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0190","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/jnci\/81.8.570","article-title":"Delivery of novel therapeutic agents in tumors \u2014 physiological barriers and strategies","volume":"81","author":"Jain","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0195","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00046364","article-title":"Vascular and interstitial barriers to delivery of therapeutic agents in tumors","volume":"9","author":"Jain","year":"1990","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0200","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1023\/A:1016434926649","article-title":"Sustained release chemotherapeutic microspheres provide superior efficacy over systemic therapy and local bolus infusions","volume":"19","author":"Emerich","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0205","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1023\/A:1007576405039","article-title":"Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors","volume":"17","author":"Emerich","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2015.05.262_bb0210","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1023\/A:1007591721877","article-title":"Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors","volume":"17","author":"Emerich","year":"2000","journal-title":"Pharm. Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591500560X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591500560X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T13:24:06Z","timestamp":1537622646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836591500560X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":42,"alternative-id":["S016836591500560X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.05.262","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-delivery of chemosensitizing siRNA and an anticancer agent via multiple monocomplexation-induced hydrophobic association","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.05.262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}